口腔癌术前加速与术后常规放疗的生活质量与成本效果:ARTSCAN 2随机试验结果
ARTSCAN 2随机对照试验比较口腔癌术前加速分次放疗与术后常规分次放疗,意向治疗人群240例。结果显示术前加速放疗在部分头颈特异生活质量领域至治疗后两年显著更差,且成本效用分析中效果更低、费用更高。术后常规放疗仍是标准治疗。
要点
- 术前加速放疗在部分QLQ-H&N35量表至治疗后两年显著劣于术后常规放疗。
- 成本效用分析中术前加速放疗效果更低且费用更高。
- 术后常规分次放疗仍为口腔癌标准治疗。
核心结论
- 术后常规分次放疗在部分头颈特异症状领域表现更少且更具成本效果。
研究设计与样本
- ARTSCAN 2随机对照试验,意向治疗人群240例,比较术前加速分次放疗与术后常规分次放疗。
- 按方案人群218例采用EORTC QLQ-C30、QLQ-H&N35和HADS在五年随访期内五个时点评估生活质量。
- 从社会视角检索直接和间接成本,以质量调整生命年(QALYs)为结局进行成本效用分析,204例纳入分析。
主要发现
- 至治疗后两年,术前加速放疗组在少数QLQ-H&N35量表上生活质量显著更差。
- 成本效用分析中术前加速放疗较术后常规放疗效果更低且费用更高。
关键数值与推荐
- 术前加速放疗:每日两次,4.5周总剂量68 Gy,4-6周后手术。
- 术后常规放疗:6-7周总剂量60或66 Gy。
临床怎么用
- 口腔癌术后常规分次放疗应继续作为标准治疗选择。
- 术前加速放疗不宜常规推荐,因其生活质量部分领域更差且成本效果不佳。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The ARTSCAN 2 randomised controlled trial compares accelerated fractionation (AF) radiotherapy (RT) in a preoperative setting with conventional fractionation (CF) RT postoperatively for oral cavity cancer (OCC). Current results indicate no advantage for preoperative AF RT, thereby reinforcing postoperative CF RT as the "gold standard" of care. This analysis of the trial focuses on health-related quality of life (HRQoL) and conducts a health-economic evaluation from a societal perspective. MATERIALS AND METHODS: 240 patients formed the intention-to-treat population. Preoperative AF RT was given twice daily during 4.5 weeks to a total dose of 68 Gy followed by surgery 4-6 weeks later. Postoperative CF RT was given to a total dose of 60 or 66 Gy during 6-7 weeks. In the per protocol population, HRQoL was assessed with the EORTC QLQ-C30, QLQ-H&N35, and HADS questionnaires at five occasions during the five-year follow-up period. Direct and indirect costs were retrieved, and a cost-utility analysis (CUA) was conducted using quality-adjusted life years (QALYs) as outcome measure. RESULTS: HRQoL was analysed in 218 patients (i.e., the per-protocol population), of whom 204 were included in the CUA. Up until two years after treatment, the preoperative AF RT-group featured significantly worse HRQoL in a few of the QLQ-H&N35 scales compared to the postoperative CF RT-group. In the CUA, preoperative AF RT was less effective and more expensive than postoperative CF RT. CONCLUSION: Postoperative CF RT is associated with fewer symptoms in selected head-and-neck-specific domains and is more cost-effective than preoperative AF RT in the treatment of OCC.
引用
- Carlwig K, Jarl J, Nilsson P, et al. Quality of life and cost-effectiveness of preoperative accelerated versus postoperative conventional radiotherapy for oral cavity cancer: Results from the randomised ARTSCAN 2 trial. Radiother Oncol. 2026. PMID: 42431267. doi:10.1016/j.radonc.2026.111688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。